So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
All content for EnRitched Menopause is the property of Jessica Ritch, MD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
Are you in your early forties and suddenly feeling like your body is betraying you with hot flashes, brain fog, or anxiety? Are you constantly asking yourself, "Is it hot, or is it just me?" You're not alone! Many women start experiencing perimenopause symptoms in their mid-30s, which can feel isolating and confusing. In this episode, we're diving into the world of perimenopause with Carin Luna-Ostaseski, a serial entrepreneur and the founder of Hot or Just Me*. Carin shares her person...
EnRitched Menopause
So many women in their 40s and 50s are trying to make informed decisions about their health, only to be met with outdated warnings, mixed messages, or advice that dismisses their very real symptoms. In this episode, Dr. Jessica Ritch breaks down the huge updates shaping the future of menopause care — including the FDA’s newly revised stance on estrogen, the shift toward earlier perimenopause treatment, advancements in personalized hormone therapy, and new insights from the 2025 Menopause Soci...
